Journal Guide

The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to such work in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: * drug, device, and biological research and development * drug screening and drug design * assessment of pharmacological activity * pharmaceutical formulation and scale-up * preclinical safety assessment * bioavailability, bioequivalence, and pharmacokinetics * phase, I, II, and III clinical development * premarket approval assessment of clinical safety * postmarketing surveillance Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

DON'T MISS A BEAT!Every informative issue of the Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) offers cardiologists, clinical pharmacologists and researchers involved in disease relevant clinical and experimental investigations of newer cardiovascular drugs and other therapeutic options. Four times a year, JCPT examines and analyzes arenas such as: o Agents that Reduce Myocardial Infarct Size o Agents that Reduce Myocardial Remodeling o Angiotensin Converting Enzyme Inhibitors o Antihypertensive Therapy o Arrhythmias o Atrial Fibrillation o Beta-Blocker Therapies o Cardioembolic Stroke o Cardiomyopathy o Cardioprotective Agents o Cardiopulmonary Resuscitation o Cardiovascular Combination Therapies o Chronic Angina o Chronic Cardiac Ischemia o Congestive Heart Failure o Coronary Artery Disease o Coronary Revascularization o Heparin Therapies o Hypertension o Hypotension o Implantable Devices o Ischemic Heart Disease o Myocardial Infarction o Percutaneous Coronary Interventions o Peripheral Arterial Disease o Preconditioning/Postconditioning o Regenerative Cardiology o Stem Cell TherapyAmong the drug classes regularly evaluated are: ACE inhibitors * angiotensin receptor blockers * anti-anginals * anti-arrhythmics * anti-coagulants * anti-hypertensives * anti-thrombins * beta-blockers * calcium channel blockers * cardioprotective agents * cardiotonic agents * direct renin inhibitors * diuretics * fibrinolytic agents * heart rate modulats * plasminogen activators * QT prolonging drugs * statins * vasoconstrictor agents * and vasodilator agents.The journal features original articles, topical journal supplements, reviews, clinical and experimental investigations, and commentaries written by respected practitioners from all over the world.

SUBSCRIBE TO THE Journal of Chemotherapyto help keep you up-to-date on antimicrobial chemotherapy,anticancer chemotherapy, immunomodulating chemotherapy,experimental and clinical studies in these fields published bimonthly.

Journal of Child and Adolescent Psychopharmacology is a peer-reviewed journal covering the clinical aspects of treating adolescents and children with psychotropic medications. The Journal encompasses treatment techniques, clinical management, investigative research, and health policy.Coverage includes:• The most up-to-date information on new drugs and treatment strategies• Analysis of biological aspects of psychopathology• In-depth studies on the adverse drug effects following treatment of psychiatric disorders• Information on related areas of medical sciences• Related news and issues in child and adolescent psychopharmacology.

This leading publication in psychopharmacology offers a wide range of articles that report on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, medico-legal issues, and psychiatric effects of non-psychiatric drugs. The Journal keeps psychiatrists and psychiatric residents up-to-date on the latest clinical developments in the psychotropics, presenting the extensive coverage needed to keep up with every development in this fast-growing field. For more information, visit www.psychopharmacology.com.